多毛症与非多毛症多囊卵巢综合征妇女基线特征与临床结局(4)
[16]Glintborg D，Rubin K H，Nybo M，et al.Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome[J].Cardiovascular Diabetology，2018，17(1)：37.
[17]Comim F V，Wippel C S，Copês R M，et al.Higher prevalence of clinical cardiovascular comorbidities in postmenopausal women with selfreported premenopausal hirsutism and/or oligoamenorrhea[J].Dermatoendocrinol，2017，9(1)：e1356517.
[18]戴蓓蓓，任蕓芸，张珏华，等.多毛和非多毛多囊卵巢综合征三维能量多普勒超声及内分泌指标特征[J].中国超声医学杂志，2015，31(1)：5356.
[19]zdemir S，zdemir M，Grkemli H，et al.Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism[J].Acta Obstetricia Et Gynecologica Scandinavica，2010，89(2)：199204.
[20]Demir B，Pasa S，Demir S，et al.Hirsutism score and the severity of hyperandrogenism associated with polycystic ovary syndrome in the southeastern region of Turkey[J].Journal of International Medical Research，2011，39(4)：15291535.
[21]Skrgatic L，Baldani D P，Cerne J Z，et al.CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels[J].J Steroid Biochem Mol Biol，2012，128(35)：107112.
[22]Slayden S M，Moran C，Jr S W，et al.Hyperandrogenemia in patients presenting with acne[J].Fertility & Sterility，2001，75(5)：889892.
[23]Lin L H，Baracat M C，Maciel G A，et al.Androgen receptor gene polymorphism and polycystic ovary syndrome[J].International Journal of Gynaecology & Obstetrics the Official Organ of the International Federation of Gynaecology & Obstetrics，2013，120(2)：115118.
[24]Zhang C，Dang J，Pei L，et al.Relationship of 2D：4D finger ratio with androgen receptor CAG and GGN repeat polymorphism[J].American Journal of Human Biology，2013，25(1)：101106.
(2018-05-17收稿责任编辑：徐颖), http://www.100md.com(高敬书 何慧 王宇)
[17]Comim F V，Wippel C S，Copês R M，et al.Higher prevalence of clinical cardiovascular comorbidities in postmenopausal women with selfreported premenopausal hirsutism and/or oligoamenorrhea[J].Dermatoendocrinol，2017，9(1)：e1356517.
[18]戴蓓蓓，任蕓芸，张珏华，等.多毛和非多毛多囊卵巢综合征三维能量多普勒超声及内分泌指标特征[J].中国超声医学杂志，2015，31(1)：5356.
[19]zdemir S，zdemir M，Grkemli H，et al.Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism[J].Acta Obstetricia Et Gynecologica Scandinavica，2010，89(2)：199204.
[20]Demir B，Pasa S，Demir S，et al.Hirsutism score and the severity of hyperandrogenism associated with polycystic ovary syndrome in the southeastern region of Turkey[J].Journal of International Medical Research，2011，39(4)：15291535.
[21]Skrgatic L，Baldani D P，Cerne J Z，et al.CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels[J].J Steroid Biochem Mol Biol，2012，128(35)：107112.
[22]Slayden S M，Moran C，Jr S W，et al.Hyperandrogenemia in patients presenting with acne[J].Fertility & Sterility，2001，75(5)：889892.
[23]Lin L H，Baracat M C，Maciel G A，et al.Androgen receptor gene polymorphism and polycystic ovary syndrome[J].International Journal of Gynaecology & Obstetrics the Official Organ of the International Federation of Gynaecology & Obstetrics，2013，120(2)：115118.
[24]Zhang C，Dang J，Pei L，et al.Relationship of 2D：4D finger ratio with androgen receptor CAG and GGN repeat polymorphism[J].American Journal of Human Biology，2013，25(1)：101106.
(2018-05-17收稿责任编辑：徐颖), http://www.100md.com(高敬书 何慧 王宇)